logo
Finwire

Finwire

Y-intercept new public short seller in Chemometec

Y-intercept has taken a public short position of 1.00 percent in the medical technology company Chemometec.

In total, 3.70 percent of the capital is shorted in the company, placing Chemometec in tenth place among the most shorted Danish companies.

Share this post

Verifierad av MonsterInsights